| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
94,622 |
87,103 |
$2.11M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
23,715 |
23,553 |
$1.70M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
62,963 |
59,650 |
$1.10M |
| 87428 |
|
12,488 |
12,317 |
$751K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,220 |
5,210 |
$549K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
18,709 |
18,682 |
$454K |
| G9920 |
Screening performed and negative |
10,541 |
10,526 |
$454K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,733 |
6,416 |
$339K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,604 |
4,523 |
$206K |
| 99205 |
Prolong outpt/office vis |
1,181 |
1,180 |
$149K |
| 99215 |
Prolong outpt/office vis |
981 |
902 |
$96K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
821 |
806 |
$84K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,520 |
1,373 |
$67K |
| 90674 |
|
1,696 |
1,696 |
$60K |
| G9919 |
Screening performed and positive and provision of recommendations |
1,377 |
1,369 |
$59K |
| 90836 |
|
465 |
441 |
$38K |
| 0011A |
|
936 |
936 |
$36K |
| 90750 |
|
184 |
184 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,054 |
4,993 |
$35K |
| 0012A |
|
857 |
857 |
$34K |
| 86580 |
|
8,729 |
8,677 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,299 |
2,185 |
$29K |
| 90715 |
|
709 |
708 |
$28K |
| 81003 |
|
14,082 |
13,554 |
$27K |
| 90661 |
|
791 |
790 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
598 |
532 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,784 |
1,362 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,490 |
2,480 |
$21K |
| 0064A |
|
515 |
515 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,497 |
1,426 |
$15K |
| H0049 |
Alcohol and/or drug screening |
623 |
619 |
$15K |
| 99385 |
|
1,270 |
1,269 |
$11K |
| 93000 |
|
1,005 |
1,000 |
$10K |
| 99000 |
|
2,653 |
2,621 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,924 |
2,922 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
234 |
234 |
$8K |
| 90686 |
|
278 |
277 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,020 |
978 |
$6K |
| 99406 |
|
371 |
371 |
$6K |
| 69209 |
|
367 |
354 |
$5K |
| 81025 |
|
1,782 |
1,761 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,500 |
2,484 |
$4K |
| H0050 |
Alcohol and/or drug services, brief intervention, per 15 minutes |
87 |
85 |
$4K |
| 99386 |
|
482 |
482 |
$3K |
| 87420 |
|
564 |
562 |
$2K |
| 0134A |
|
27 |
27 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
19 |
$1K |
| 0001A |
|
25 |
25 |
$1K |
| 90746 |
|
13 |
13 |
$972.92 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
55 |
55 |
$829.71 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
102 |
101 |
$718.25 |
| 0054A |
|
15 |
15 |
$600.00 |
| 0004A |
|
15 |
15 |
$600.00 |
| 72100 |
|
13 |
13 |
$507.02 |
| 0071A |
|
12 |
12 |
$480.00 |
| 90480 |
|
12 |
12 |
$480.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
21 |
21 |
$377.19 |
| 85018 |
|
172 |
171 |
$350.44 |
| 82947 |
|
97 |
92 |
$309.86 |
| 90651 |
|
18 |
18 |
$243.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
21,312 |
21,223 |
$213.03 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
24 |
$133.96 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
27 |
27 |
$82.24 |
| 92551 |
|
86 |
86 |
$29.11 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,134 |
1,120 |
$11.35 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.45 |
| 3078F |
|
7,108 |
6,844 |
$0.00 |
| 3077F |
|
4,303 |
4,102 |
$0.00 |
| 3046F |
|
29 |
28 |
$0.00 |
| 99499 |
|
2,264 |
2,262 |
$0.00 |
| 4004F |
|
383 |
383 |
$0.00 |
| 3074F |
|
8,164 |
7,834 |
$0.00 |
| 3080F |
|
2,461 |
2,369 |
$0.00 |
| 1036F |
|
35,171 |
33,901 |
$0.00 |
| G8433 |
Screening for depression not completed, documented patient or medical reason |
3,235 |
3,201 |
$0.00 |
| 3079F |
|
4,463 |
4,322 |
$0.00 |
| 3075F |
|
1,945 |
1,902 |
$0.00 |
| 3044F |
|
1,453 |
1,450 |
$0.00 |